Manchester Financial Inc Moderna, Inc. Transaction History

Manchester Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$129.91 - $234.98 $34,556 - $62,504	-266 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$109.18 - $185.98 $14,630 - $24,921	134 Added 101.52%	266 $35,000
Q4 2020 Jan 26, 2021	BUY	$65.74 - $169.86 $4,273 - $11,040	65 Added 97.01%	132 $14,000
Q3 2020 Oct 15, 2020	BUY	$54.34 - $94.85 $2,499 - $4,363	46 Added 219.05%	67 $5,000
Q2 2020 Jul 13, 2020	SELL	$29.67 - $80.0 $14,211 - $38,320	-479 Reduced 95.8%	21 $1,000
Q1 2020 Apr 20, 2020	BUY	$17.78 - $31.58 $8,890 - $15,790	500 New	500 $15,000

1,114

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $24.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.